Diabetic Living USA – July 2019

(Ron) #1
What are the diff erent
insulin types all about?
—Confused By My Options

Dear Confused,
Th e goal of insulin therapy is to keep
blood sugar as close to your target range
as possible. Diff erent forms of insulin just
provide fl exibility. Th ere are fi ve types,
named for how quickly they begin to
work and for how long they lower blood
sugar: rapid-acting, short-acting, interme-
diate-acting, long-acting, and premixed.
Th ese types fall into two main categories
based on their functionality: basal and
bolus formulations. (See chart, right.)
Basal insulin is taken regardless of
food intake. It acts slowly and steadily
to help shutt le glucose from the blood-
stream into cells, especially between
meals. Long- and intermediate-acting
forms help satisfy basal insulin needs.
Intermediate-acting insulins are typically
prescribed to be injected twice daily.
Long-acting forms are injected once per
day to cover up to a 24-hour period.
Bolus insulin is used when you are
eating or need to correct an elevated
blood sugar. Bolus insulins are all rapid-
or short-acting. Th ey reduce blood sugar
very quickly and stop acting within a mat-
ter of hours. Aside from Afreeza, which
is inhaled, these types of insulin can be
injected or used in a pump.
Premixed insulins usually combine
a bolus and a basal insulin in the same
product, so they may require less injec-
tions. But fi nding the right dose can be
challenging.
Insulin is the most eff ective treat-
ment for diabetes, but one size does
not fi t all. Speak with your doctor or
diabetes educator about the best choice
for you.

TOBY SMITHSON, M.S., RDN, CDE,


has been living with type 1 diabetes
and using insulinfor over 50
years, although her insulin regimen has
evolved over time. Currently she uses
rapid-acting insulin in a pump for a
more fl exible routine.

Common Insulin Types
The generic name is on
the left with the corresponding
brand name(s) on the right.

BOLUS


RAPID-ACTING


SHORT-ACTING


Aspart

Glulisine

Lispro

Inhaled
Regular

Human Regular
Humulin R,
Novolin R

Fiasp,
Novolog

Apidra
Humalog,
Admelog

Afreeza

BASAL


LONG-ACTING


INTERMEDIATE-ACTING


Degludec

Detemir

Glargine

Human NPH
Humulin N,
Novolin N

Tresiba

Levemir
Lantus, Toujeo,
Basaglar

PREMIXED


PREMIXED PRODUCTS


PREMIXED / GLP-1 RECEPTOR


AGONIST PRODUCTS


Lispro 75 ⁄ 25 ,
50 ⁄ 50

NPH/Regular
70 ⁄ 30

Degludec/
Liraglutide
Glargine/
Lixisenatide

Xultophy

Soliqua

Humalog Mix
75 ⁄ 25 , 50 ⁄ 50

Humulin 70 ⁄ 30 ,
Novolin 70 ⁄ 30

Aspart 70 ⁄ 30 Novolog Mix 70 ⁄ 30

Ask Toby

THE PUMP


Tandem Diabetes


Care t:slim X


THE


SOFTWARE


Control IQ


technology


THE CGM


Dexcom G


THE


VISION


PHOTO COURTESY TANDEM DIABETES CARE


THE


DIFFERENCE


The pump and software
use the CGM sensor
values to predict glucose
levels and adjust insulin
delivery to prevent highs
and lows.


THE GOAL


Better time in range and
improved A1C. Studies
in the pipeline are
promising ... stay tuned!


Here’s how the t:slim X
can be paired with smart
software and a CGM to
create an innovative hy-
brid closed-loop system.

Free download pdf